Apyx medical corporation to release third quarter of fiscal year 2023 financial results on november 9, 2023

Clearwater, fla.--(business wire)--apyx® medical corporation (nasdaq:apyx) (the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that financial results for the third quarter of fiscal year 2023 will be released before the market opens on thursday, november 9th. management will host a conference call at 8:00 a.m. eastern time on november 9th to discuss the results of the quarter, and to host a question and a.
APYX Ratings Summary
APYX Quant Ranking